ANGO
HoldPremium GrowerAngioDynamics, Inc. · Healthcare · United States · $655M · Avg Vol: $6M/d
Premium Grower: Strong business with the market behind it, but you are paying up for it.
ABOUT ANGIODYNAMICS, INC.
Read
AngioDynamics, Inc. designs, manufactures, and sells innovative medical devices for minimally invasive diagnosis and treatment across areas like peripheral vascular disease and oncology. Its competitive moat is built upon proprietary technologies such as the NanoKnife for irreversible electroporation and the AngioVac for vascular thrombus management, serving critical unmet medical needs. The company maintains strong relationships within the medical community, continuously innovating in its specialized therapeutic segments.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 316.2M | 338.8M | 303.9M | 292.5M | -2.6% | 320.2M | 308.2M | 324.5M | 3.5% |
| EPS | — | -0.68 | -1.33 | -4.59 | -0.83 | — | -0.88 | — | — | — |
| Shares | — | 39.2M | 39.6M | 40.4M | 41.0M | +4.7% | 41.3M | — | — | — |
| Debt | 20.0M | 33.8M | 64.6M | 4.7M | — | -38.2% | 11.0M | — | — | — |
| Equity | — | 424.5M | 378.3M | 205.6M | 183.0M | -24.5% | — | — | — | — |
| Op CF | — | -7.2M | 78.0K | -28.2M | -10.1M | — | 3.1M | — | — | — |
| Inv CF | — | -19.3M | -9.7M | 123.7M | -10.2M | — | — | — | — | — |
| Fin CF | — | 7.7M | 25.4M | -64.2M | -0.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ANGO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ANGO | AngioDynamics, Inc.(you) | $655M | 52 | Hold |
| STAA | STAAR Surgical Company | $1.1B | 57 | Hold |
| LMAT | LeMaitre Vascular, Inc. | $1.8B | 53 | Hold |
| AZTA | Azenta, Inc. | $1.4B | 46 | Hold |
| BLFS | BioLife Solutions, Inc. | $1.8B | 50 | Hold |
| SMTI | Sanara MedTech Inc. | $318M | 68 | Buy |
| XRAY | DENTSPLY SIRONA Inc. | $2.2B | 58 | Hold |
| OSUR | OraSure Technologies, Inc. | $248M | 33 | Sell |
| ATRC | AtriCure, Inc. | $2.5B | 64 | Hold |
| KMTS | Kestra Medical Technologies, Ltd. | $1.5B | 26 | Sell |
Peer medians: ROE -31.0% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.